• Language: English
    • Italiano Italiano
    • English English

CNCCS

MENU
  • Home
  • Chemical Compounds
    • Compound Collection
    • Our Laboratories
  • Centre for rare diseases
    • Research Areas
    • Rare Diseases
    • Neglected and Poverty Diseases
  • Bioeconomy
    • Edition 2014
    • Edition 2013
    • Edition 2012
    • Edition 2011
  • Media
    • Press Review
    • videos
    • Video Gallery
  • Policies and Certifications
  • Contact Us
    • Job Opportunities

(Italiano) Oxford vaccine up to 90% effective – trials

24 November 2020 Comments (0)  Like

Sorry, this entry is only available in Italian.

 Like (Italiano) Oxford vaccine up to 90% effective – trials

About the Author: info@iwebyou.it

Comments are closed.

Recent Posts

  • (Italiano) Oxford vaccine up to 90% effective – trials
  • (Italiano) Interview with Piero Di Lorenzo «The Oxford vaccine has an efficacy of 90%»
  • (Italiano) Interview with Matteo Liguori. Research needs time
  • (Italiano) “The vaccine activates many antibodies”. Steps forward thanks to the tests on elderly people
  • (Italiano) Covid vaccine, IRBM (Pomezia, Rome): «First doses of AstraZeneca vaccine within December, the clinical trials are about to be completed»

Contact Us

Ph: +39.06.91093692
Fax: +39.06.91093654
Mail: info@cnccs

CNCCS Scarl
Collection of National Chemical Compounds and Screening Center
Via Pontina km 30,600 – 00071 Pomezia (RM)

News

  • (Italiano) Oxford vaccine up to 90% effective – trials
  • (Italiano) Interview with Piero Di Lorenzo «The Oxford vaccine has an efficacy of 90%»
  • (Italiano) Interview with Matteo Liguori. Research needs time
  • (Italiano) “The vaccine activates many antibodies”. Steps forward thanks to the tests on elderly people

(Italiano) Compliance

  • Privacy
  • Cookies policy
  • Code of Ethics
  • Codice Etico
  • Modello Organizzativo di Gestione e Controllo ex D.Lgs. 231/2001 – Parte generale_allegato

Partners